COBALFER-FCM INJ.
MRP: 1,700
Packaging: 10 ML
Pack Type: injection
Composition:
Ceftriaxone 1000mg + Tazobactam 125mg
Indication:
Restores the iron stores in short duration of time as compared to Iron Sucrose, Improves outcomes for patients with heart failure
Description:
CeftriTazo-1125 is a synergistic combination of Ceftriaxone, a third-generation cephalosporin, and Tazobactam, a β-lactamase inhibitor. This powerful duo broadens the antibacterial spectrum and is effective against beta-lactamase producing resistant organisms.
Tags:
- Broad-spectrum antibacterial activity
- Effective against resistant β-lactamase producing strains
- Once or twice daily administration
- Improved clinical efficacy in mixed infections
- Excellent tissue penetration
Usage Information
Dosage
Route: Intravenous (IV) or Intramuscular (IM) Adult Dose: Usual: 1.125 g every 12 hours or as directed by the physician Maximum: Up to 4 g per day (Ceftriaxone basis), depending on infection severity Reconstitute with sterile water before administration. Administer under medical supervision only.
Side Effects
Common: Local pain at injection site Diarrhea, nausea Rash or allergic reaction Rare/Serious: Hepatic dysfunction Pseudomembranous colitis Hematological changes (eosinophilia, thrombocytopenia) Anaphylactic reactions in hypersensitive individuals
Contraindications
Known allergy to cephalosporins or penicillins Neonates with hyperbilirubinemia Concurrent calcium-containing IV solutions in neonates Severe hepatic/renal impairment (caution advised)
Availability
Ceftriaxone Tazobactam injection 1g + 125mg antibiotic injection Beta-lactamase inhibitor combination Ceftriaxone with Tazobactam use Broad-spectrum antibiotic for severe infections